Drug Manufacturers - Specialty & Generic Companies By Current Asset
LargestBiggest EarnersMost ProfitableMost LiquidHighly LeveragedTop DividendsCapital-HeavyHighest ValuationLargest Workforce
Current Asset
| Current Asset | Efficiency | Market Risk | Exp Return | ||||
|---|---|---|---|---|---|---|---|
| 1 | LNTH | Lantheus Holdings | (0.05) | 3.66 | (0.19) | ||
| 2 | RMTI | Rockwell Medical | (0.03) | 6.98 | (0.19) | ||
| 3 | BIOA | BioAge Labs, | 0.05 | 5.51 | 0.25 | ||
| 4 | KALY | Kali Inc | 0.00 | 0.00 | 0.00 | ||
| 5 | KGET | Kleangas Energy Tech | 0.00 | 0.00 | 0.00 | ||
| 6 | NSRS | North Springs Resources | 0.00 | 0.00 | 0.00 |
The analysis above is based on a 90-day investment horizon and a default level of risk. Use the Portfolio Analyzer to fine-tune all your assumptions. Check your current assumptions here.
Current Asset is all of the company's assets that can be used to pay off current liabilities within the current fiscal period or over the next 12 months. Current Asset includes cash or cash equivalents, accounts receivable, short-term investments, and the portion of prepaid liabilities which will be paid within the next 12 months. Because these assets are easily turned into cash, they are sometimes referred to as liquid assets. Current Asset is important to company's creditors and private equity firms as they will often be interested in how much that company has in current assets since these assets can be easily liquidated in case the company goes bankrupt. However, it is usually not enough to know if a company is in good shape just based on current asset alone; the amount of current liabilities should always be considered.